Concepedia

Raluca Verona

RV

Statistics

Publications

51

Citations

5.9K

H-Index

34

Active since

1997

Affiliations

Janssen (United States)(Current)

Vrije Universiteit Amsterdam

Amsterdam University Medical Centers

University of Pennsylvania

City of Hope

Raluca Verona is an author at Janssen (United States) specializing in immunotherapy, cancer immunotherapy, and multiple myeloma.

ORCID

Publications per year

1997–2025

51

Publications

51

Teclistamab in Relapsed or Refractory Multiple Myeloma

Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk et al. · New England Journal of Medicine · 2022 · 1.1K citations · Full text

, , +17

Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma

Ajai Chari, Monique C. Minnema, Jesús G. Berdeja et al. · New England Journal of Medicine · 2022 · 649 citations · Full text

, , +17

Selective loss of imprinting in the placenta following preimplantation development in culture

Mellissa R.W. Mann, Susan S. Lee, Adam S. Doherty et al. · Development · 2004 · 429 citations

, , +17

<i>E2f3</i> is critical for normal cellular proliferation

Patrick O. Humbert, Raluca Verona, Jeffrey M. Trimarchi et al. · Genes & Development · 2000 · 346 citations · Full text

, , +13

Disruption of Imprinted Gene Methylation and Expression in Cloned Preimplantation Stage Mouse Embryos1

Mellissa R.W. Mann, Young Gie Chung, Leisha D. Nolen et al. · Biology of Reproduction · 2003 · 312 citations · Full text

, , +17

1–5 of 51